ZDZimu Deng

Zimu Deng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zimu Deng has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Anthony K. Shum

    Cardiovascular Research Institute, University of California, San Francisco (C.S.L., A.K.S.).

    1 shared publication
  • Bradley J. Backes

    Department of Medicine, University of California, San Francisco, San Francisco, CA 1

    1 shared publication
  • Christopher S. Law

    Department of Medicine, University of California, San Francisco, San Francisco, CA 1

    1 shared publication
  • Frances O. Ho

    Department of Medicine, University of California, San Francisco, San Francisco, CA 1

    1 shared publication
  • Kojiro Mukai

    Laboratory of Organelle Pathophysiology, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Sendai, Japan

    1 shared publication
  • Tereza Martinu

    Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, Ontario, Canada 3

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome

    by Zimu Deng, Zhenlu Chong, Christopher S. Law, Kojiro Mukai, Frances O. Ho, Tereza Martinu, Bradley J. Backes, Walter L. Eckalbar, Tomohiko Taguchi, Anthony K. Shum

    Pathogenic COPA variants cause a Mendelian syndrome of immune dysregulation with elevated type I interferon signaling. COPA is a subunit of coat protein complex I (COPI) that mediates Golgi to ER transport. Missense mutations of the COPA WD40 domain impair binding and sorting of proteins targeted for ER retrieval, but how this causes disease remains unknown. Given the importance of COPA in Golgi–ER transport, we speculated that type I interferon signaling in COPA syndrome involves missorting of STING. We show that a defect in COPI transport causes ligand-independent activation of STING. Furthermore, SURF4 is an adapter molecule that facilitates COPA-mediated retrieval of STING at the Golgi. Activated STING stimulates type I interferon–driven inflammation in CopaE241K/+ mice that is rescued in STING-deficient animals. Our results demonstrate that COPA maintains immune homeostasis by regulating STING transport at the Golgi. In addition, activated STING contributes to immune dysregulation in COPA syndrome and may be a new molecular target in treating the disease.